HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuyuki Ohmoto Selected Research

gemilukast

8/2015Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuyuki Ohmoto Research Topics

Disease

1Underactive Urinary Bladder
01/2018
1Bone Resorption
01/2016
1Asthma (Bronchial Asthma)
08/2015
1Osteoporosis
11/2014

Drug/Important Bio-Agent (IBA)

1ONO-8055IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2016
1deoxypyridinolineIBA
01/2016
1OsteocalcinIBA
01/2016
1gemilukastIBA
08/2015
1ONO-5334IBA
11/2014
1Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2014

Therapy/Procedure

1Therapeutics
11/2014